Jump Financial, LLC Scholar Rock Holding Corp Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.63 - $9.71 $729,351 - $928,178	-95,590 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$7.84 - $16.79 $383,807 - $821,954	48,955 Added 104.97%	95,590 $796,000
Q1 2024 May 13, 2024	BUY	$13.2 - $17.76 $615,582 - $828,237	46,635 New	46,635 $828,000
Q4 2022 Feb 13, 2023	SELL	$7.02 - $9.76 $228,353 - $317,483	-32,529 Reduced 73.1%	11,971 $108,000
Q3 2022 Nov 07, 2022	BUY	$5.33 - $11.3 $237,185 - $502,850	44,500 New	44,500 $308,000
Q2 2022 Aug 09, 2022	SELL	$4.66 - $13.96 $60,580 - $181,480	-13,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$11.89 - $24.68 $154,570 - $320,840	13,000 New	13,000 $168,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $1.55B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.